로딩 중…
지수 로딩 중…
Summit Therapeutics Inc.
SMMT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$13.75-2.27%
2026-06-18
Price Chart
Summit Therapeutics Inc.-31.80%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $10.67B |
| Revenue | $0.00 |
| Net Income | $-1.05B |
| Total Assets | $491M |
| Net Assets | $414M |
| Value | |
| P/B | 25.78x |
| FCF Yield | -2.69% |
| Financial Health | |
| Debt Ratio | 18.67% |
| Total Debt | $15M |
| FCF | $-287M |
| Cash | $81M |
| Current Ratio | 7.41x |
| Performance | |
| 1Y Return | -31.80% |
| 1M Return | -13.25% |
| From 52W High | -55.62% |
| 1Y MDD | -62.26% |
| Trading | |
| Volume | 7,255,913 shares |
| Trading Value | $101M |
| Per Share | |
| EPS | $-1.44 |
| BPS | $0.88 |